DMTweet: a psychedelic tweet recap

a PsyMed Ventures x Business Trip colab (issue #4)

DMTweet is a newsletter of psychedelic tweets that catch our eye 👀.

This is a collaboration between PsyMed Ventures and Business Trip (yes, we’re the folks working on both 🙃).

Tweets include: Industry updates 💼, Therapy 🛋️, Psychedelic research 🧪, Neuroscience 🧠, Consciousness ✨, Indigenous reciprocity ⚖️, Regulatory updates 📜, and Trippy ideas 👽.

Inclusion = interesting ≠ endorsement.

Let’s get to it….

Natán Ponieman @natanponieman

LSD And Magic Mushroom's Active Compound Appear To Have The Same Effects, New Study @mindmedco Finds | For @Benzinga $MNMD

benzinga.comLSD And Magic Mushroom’s Active Compound Appear To Have The Same Effects, New Study Finds | Benzinga

Javier González Maeso @jgmaeso

Just published by ⁦@JasterAlaina⁩ et al - the 5-HT2A antagonist volinanserin blocks DOI- and mescaline-induced, but not LSD- or psilocybin-induced, ICSS depression in rats - the same 5-HT2A antagonist blocked HTR induced by DOI and LSD in mice

link.springer.comEffects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by diff…Background Clinical studies suggest that psychedelics exert robust therapeutic benefits in a number of psychiatric conditions including substance use disorder. Preclinical studies focused on safety and efficacy of these compounds are necessary to determine the full range of psychedelics’ effects. Ob…

Matthew W. Johnson @Drug_Researcher

I was interviewed about microdosing by National Geographic. "How can we use microdosing research to understand more about the nature of the human mind?” Lots of great comments from colleagues.

nationalgeographic.comCan microdosing psychedelics boost mental health? Here’s what the evidence shows.Taking tiny doses of drugs like psilocybin, LSD, and ayahuasca is gaining popularity. But the benefits are still being investigated.

Celia Morgan @profceliamorgan

Does anyone out there know of any psychedelic treatment studies looking at integration vs no integration (or length of integration) and impact on primary outcomes? @ManojDoss? @drrosalindwatts?

(⬆️ click tweet for replies ⬆️)

Neşe Devenot, PhD @NeseLSD

Call for Papers on Psychedelic Capitalism! Edited by @LucRichert, guest edited by @brian_pace & me.🍄 "The aim...is to contribute to critical discussions around relatively underexplored socio-economic, business, and capitalist histories of psychedelics." uwpress.wisc.edu/blog/?p=6236

uwpress.wisc.eduCall for Papers: Psychedelic Capitalism: From Forest Retreat to Fortune 500 and PharmaciesHistory of Pharmacy and Pharmaceuticals, the official journal of the American Institute of the History of Pharmacy (AIHP), is pleased to announce a call for papers for a special issue: “Psychedelic…

Greg Kubin @kubeans

What do u think is the most important unsolved problem in psychedelic medicine?

Rally Queens @rally_queens

Why is it always “your brain on drugs” and never “our brain letting go of ego and tapping into the greater meaning of our existence”?

S. x Uzamaki @steelthehero

If you could summarize your mental health at the moment with a gif, what would it look like?

Until next time…

Greg, Matias, and Dina

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄🍄

DMTweet is a collab between PsyMed Ventures and Business Trip. PsyMed Ventures is a community-focused fund and syndicate investing in psychedelic medicine and mental health tech. Business Trip is a podcast about psychedelic entrepreneurship. Our mission is to help expand access to psychedelic medicine and mental health.